Johnson & Johnson Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Johnson & Johnson (JNJ) slipped 0.36% to $163.93 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.95% to 4,395.64 and the Dow Jones Industrial Average rising 1.00% to 34,258.32. Johnson & Johnson closed $15.99 short of its 52-week high ($179.92), which the company achieved on August 20th.
The stock underperformed when compared to some of its competitors Wednesday, as Roche Holding AG Part. Cert. rose 2.27% to $374.96, Merck & Co. Inc. (MRK) rose 0.10% to $72.04, and Pfizer Inc. (PFE) rose 0.07% to $43.95. Trading volume (5.7 M) remained 110,320 below its 50-day average volume of 5.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 22, 2021.
(END) Dow Jones Newswires
September 22, 2021 16:33 ET (20:33 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.